{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:44:55Z","timestamp":1766137495821,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1208\/s12249-020-01796-9","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T16:03:43Z","timestamp":1599235423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enhancing the Furosemide Permeability by Papain Minitablets Through a Triple Co-culture In Vitro Intestinal Cell Model"],"prefix":"10.1208","volume":"21","author":[{"given":"F\u00falvio G.","family":"Corazza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia V.","family":"Ernesto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe A. N.","family":"Nambu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro A.","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo H. C.","family":"Varca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-534X","authenticated-orcid":false,"given":"Daniel P.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia R.","family":"Leite-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton","family":"Andr\u00e9o-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia S.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"1796_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejpb.2016.11.034","volume":"112","author":"AY Abuhelwa","year":"2017","unstructured":"Abuhelwa AY, Williams DB, Upton RN, Foster DJR. Food, gastrointestinal pH, and models of oral drug absorption. Eur J Pharm Biopharm. 2017;112:234\u201348. https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.034.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/J.IJPHARM.2010.05.003","volume":"395","author":"JF Pinto","year":"2010","unstructured":"Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395:44\u201352. https:\/\/doi.org\/10.1016\/J.IJPHARM.2010.05.003.","journal-title":"Int J Pharm"},{"key":"1796_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/J.ADDR.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/J.ADDR.2016.06.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"1796_CR4","doi-asserted-by":"publisher","first-page":"101413","DOI":"10.1016\/j.jddst.2019.101413","volume":"55","author":"FG Corazza","year":"2020","unstructured":"Corazza FG, Ernesto JV, Nambu FAN, de Carvalho LR, Leite-Silva VR, Varca GHC, et al. Papain-cyclodextrin complexes as an intestinal permeation enhancer: permeability and in vitro safety evaluation. J Drug Deliv Sci Technol. 2020;55:101413. https:\/\/doi.org\/10.1016\/j.jddst.2019.101413.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1796_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ijpharm.2017.08.059","volume":"530","author":"C Leichner","year":"2017","unstructured":"Leichner C, Menzel C, Laffleur F, Bernkop-Schn\u00fcrch A. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS). Int J Pharm. 2017;530:346\u201353. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.059.","journal-title":"Int J Pharm"},{"key":"1796_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/03639045.2013.877481","volume":"41","author":"GHC Varca","year":"2015","unstructured":"Varca GHC, Lopes PS, Ferraz HG. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach. Drug Dev Ind Pharm. 2015;41:430\u20135. https:\/\/doi.org\/10.3109\/03639045.2013.877481.","journal-title":"Drug Dev Ind Pharm"},{"key":"1796_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1248\/yakushi.131.697","volume":"131","author":"M Sharma","year":"2011","unstructured":"Sharma M, Sharma V, Panda AK, Majumdar DK. Enteric microsphere formulations of papain for oral delivery. Yakugaku Zasshi. 2011;131:697\u2013709. https:\/\/doi.org\/10.1248\/yakushi.131.697.","journal-title":"Yakugaku Zasshi"},{"key":"1796_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11051-019-4719-7","volume":"22","author":"H Zafar","year":"2020","unstructured":"Zafar H, Kiani MH, Raza F, Rauf A, Chaudhery I, Ahmad NM, et al. Design of enzyme decorated mucopermeating nanocarriers for eradication of H pylori infection. J Nanopart Res. 2020;22:4. https:\/\/doi.org\/10.1007\/s11051-019-4719-7.","journal-title":"J Nanopart Res"},{"key":"1796_CR9","doi-asserted-by":"publisher","unstructured":"Issa MG, de Souza NV, Duque MD, Ferraz HG. Physical characterization of multiparticulate systems. Brazilian J Pharm Sci. 2017;53. https:\/\/doi.org\/10.1590\/s2175-97902017000400216.","DOI":"10.1590\/s2175-97902017000400216"},{"key":"1796_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijpharm.2011.06.027","volume":"416","author":"C Tissen","year":"2011","unstructured":"Tissen C, Woertz K, Breitkreutz J, Kleinebudde P. Development of mini-tablets with 1 mm and 2 mm diameter. Int J Pharm. 2011;416:164\u201370. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.06.027.","journal-title":"Int J Pharm"},{"key":"1796_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1517\/17425247.2014.951633","volume":"12","author":"A Aleksovski","year":"2015","unstructured":"Aleksovski A, Dreu R, Ga\u0161perlin M, Planin\u0161ek O. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert Opin Drug Deliv. 2015;12:65\u201384. https:\/\/doi.org\/10.1517\/17425247.2014.951633.","journal-title":"Expert Opin Drug Deliv"},{"key":"1796_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jconrel.2011.07.003","volume":"156","author":"AK Shah","year":"2011","unstructured":"Shah AK, Agnihotri SA. Recent advances and novel strategies in pre-clinical formulation development: an overview. J Control Release. 2011;156:281\u201396. https:\/\/doi.org\/10.1016\/j.jconrel.2011.07.003.","journal-title":"J Control Release"},{"key":"1796_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","volume":"175","author":"P Artursson","year":"1991","unstructured":"Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991;175:880\u20135. https:\/\/doi.org\/10.1016\/0006-291X(91)91647-U.","journal-title":"Biochem Biophys Res Commun"},{"key":"1796_CR14","doi-asserted-by":"publisher","unstructured":"Hu M, Ling J, Lin H, Chen J. Use of Caco-2 cell monolayers to study drug absorption and metabolism. Optim Drug Discov. 2004:19\u201335. https:\/\/doi.org\/10.1385\/1-59259-800-5:019.","DOI":"10.1385\/1-59259-800-5:019"},{"key":"1796_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.xphs.2015.10.030","volume":"105","author":"M \u00d6lander","year":"2016","unstructured":"\u00d6lander M, Wi\u015bniewski JR, Matsson P, Lundquist P, Artursson P. The proteome of filter-grown Caco-2 cells with a focus on proteins involved in drug disposition. J Pharm Sci. 2016;105:817\u201327. https:\/\/doi.org\/10.1016\/j.xphs.2015.10.030.","journal-title":"J Pharm Sci"},{"key":"1796_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2012.10.003","volume":"83","author":"F Antunes","year":"2013","unstructured":"Antunes F, Andrade F, Ara\u00fajo F, Ferreira D, Sarmento B. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm. 2013;83:427\u201335. https:\/\/doi.org\/10.1016\/j.ejpb.2012.10.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR17","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/jbm.b.33508","volume":"104","author":"F Ara\u00fajo","year":"2016","unstructured":"Ara\u00fajo F, Pereira C, Costa J, Barrias C, Granja PL, Sarmento B. In vitro M-like cells genesis through a tissue-engineered triple-culture intestinal model. J Biomed Mater Res - Part B Appl Biomater. 2016;104:782\u20138. https:\/\/doi.org\/10.1002\/jbm.b.33508.","journal-title":"J Biomed Mater Res - Part B Appl Biomater"},{"key":"1796_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.addr.2016.08.007","volume":"106","author":"SG Ciappellano","year":"2016","unstructured":"Ciappellano SG, Tedesco E, Venturini M, Benetti F. In vitro toxicity assessment of oral nanocarriers. Adv Drug Deliv Rev. 2016;106:381\u2013401. https:\/\/doi.org\/10.1016\/j.addr.2016.08.007.","journal-title":"Adv Drug Deliv Rev"},{"key":"1796_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.colsurfb.2018.07.022","volume":"171","author":"D Li","year":"2018","unstructured":"Li D, Zhuang J, Yang Y, Wang D, Yang J, He H, et al. Loss of integrity of doxorubicin liposomes during transcellular transportation evidenced by fluorescence resonance energy transfer effect. Colloids Surf B: Biointerfaces. 2018;171:224\u201332. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.07.022.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1796_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1021\/mp400507g","volume":"11","author":"C Schimpel","year":"2014","unstructured":"Schimpel C, Teubl B, Absenger M, Meindl C, Fr\u00f6hlich E, Leitinger G, et al. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm. 2014;11:808\u201318. https:\/\/doi.org\/10.1021\/mp400507g.","journal-title":"Mol Pharm"},{"key":"1796_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpharm.2017.04.037","volume":"525","author":"B Mitra","year":"2017","unstructured":"Mitra B, Chang J, Wu SJ, Wolfe CN, Ternik RL, Gunter TZ, et al. Feasibility of mini-tablets as a flexible drug delivery tool. Int J Pharm. 2017;525:149\u201359. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.04.037.","journal-title":"Int J Pharm"},{"key":"1796_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1590\/S1984-82502014000300008","volume":"50","author":"VJT Filho","year":"2014","unstructured":"Filho VJT, Andreazza IF, Sato MEO, Murakami FS. Development of a multiparticulate system containing enteric-release mini-tablets of omeprazole. Brazilian J Pharm Sci. 2014;50:505\u201312. https:\/\/doi.org\/10.1590\/S1984-82502014000300008.","journal-title":"Brazilian J Pharm Sci"},{"key":"1796_CR23","first-page":"658","volume":"6","author":"CC Ferraz","year":"2014","unstructured":"Ferraz CC, Varca GHC, Vila MMDC, Lopes PS. Validation of in vitro analytical method to measure papain activity in pharmaceutical formulations. Int J Pharm Pharm Sci. 2014;6:658\u201361.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1796_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"key":"1796_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejpb.2014.03.017","volume":"87","author":"A B\u00e9duneau","year":"2014","unstructured":"B\u00e9duneau A, Tempesta C, Fimbel S, Pellequer Y, Jannin V, Demarne F, et al. A tunable Caco-2\/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. Eur J Pharm Biopharm. 2014;87:290\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2014.03.017.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR26","doi-asserted-by":"publisher","first-page":"4.17.1","DOI":"10.1002\/0471143030.cb0417s37","volume":"37","author":"S Passey","year":"2007","unstructured":"Passey S, Pellegrin S, Mellor H. Scanning electron microscopy of cell surface morphology. Curr Protoc Cell Biol. 2007;37:4.17.1\u20134.17.13. https:\/\/doi.org\/10.1002\/0471143030.cb0417s37.","journal-title":"Curr Protoc Cell Biol"},{"key":"1796_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.05.022","volume":"378","author":"X Wang","year":"2009","unstructured":"Wang X, Meng M, Gao L, Liu T, Xu Q, Zeng S. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm. 2009;378:1\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.05.022.","journal-title":"Int J Pharm"},{"key":"1796_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/bf00306028","volume":"32","author":"JE Scott","year":"1972","unstructured":"Scott JE. Histochemistry of Alcian blue. 3. The molecular biological basis of staining by Alcian blue 8GX and analogous phthalocyanins. Histochemie. 1972;32:191\u2013212. https:\/\/doi.org\/10.1007\/bf00306028.","journal-title":"Histochemie."},{"key":"1796_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/bf00306176","volume":"21","author":"H Puchtler","year":"1970","unstructured":"Puchtler H, Waldrop FS, Meloan SN, Terry MS, Conner HM. Methacarn (methanol-Carnoy) fixation. Practical and theoretical considerations. Histochemie. 1970;21:97\u2013116. https:\/\/doi.org\/10.1007\/bf00306176.","journal-title":"Histochemie."},{"key":"1796_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jconrel.2012.01.041","volume":"160","author":"Y Loo","year":"2012","unstructured":"Loo Y, Grigsby CL, Yamanaka YJ, Chellappan MK, Jiang X, Mao HQ, et al. Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models. J Control Release. 2012;160:48\u201356. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.041.","journal-title":"J Control Release"},{"key":"1796_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2013.10.003","volume":"458","author":"F Ara\u00fajo","year":"2013","unstructured":"Ara\u00fajo F, Sarmento B. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies. Int J Pharm. 2013;458:128\u201334. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.10.003.","journal-title":"Int J Pharm"},{"key":"1796_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2015.01.004","volume":"97","author":"S K\u00f6llner","year":"2015","unstructured":"K\u00f6llner S, D\u00fcnnhaupt S, Waldner C, Hauptstein S. Pereira De Sousa I, Bernkop-Schn\u00fcrch A. Mucus permeating thiomer nanoparticles. Eur J Pharm Biopharm. 2015;97:265\u201372. https:\/\/doi.org\/10.1016\/j.ejpb.2015.01.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3844\/ajbbsp.2012.99.104","volume":"8","author":"E Amri","year":"2012","unstructured":"Amri E, Mamboya F. Papain, a plant enzyme of biological importance: a review. Am J Biochem Biotechnol. 2012;8:99\u2013104. https:\/\/doi.org\/10.3844\/ajbbsp.2012.99.104.","journal-title":"Am J Biochem Biotechnol"},{"key":"1796_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","volume":"13","author":"SM Frisch","year":"2001","unstructured":"Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol. 2001;13:555\u201362. https:\/\/doi.org\/10.1016\/S0955-0674(00)00251-9.","journal-title":"Curr Opin Cell Biol"},{"key":"1796_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/jnci\/34.2.231","volume":"34","author":"MA Epstein","year":"1965","unstructured":"Epstein MA, Barr YM. Characteristics and mode of growth of tissue culture strain (EB1) of human lymphoblasts from burkitt\u2019s lymphoma. J Natl Cancer Inst. 1965;34:231\u201340. https:\/\/doi.org\/10.1093\/jnci\/34.2.231.","journal-title":"J Natl Cancer Inst"},{"key":"1796_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","volume":"58","author":"M Lindenberg","year":"2004","unstructured":"Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58:265\u201378. https:\/\/doi.org\/10.1016\/j.ejpb.2004.03.001.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR37","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/jps.22030","volume":"99","author":"G Granero","year":"2010","unstructured":"Granero G, Longhi MR, Mora MJ, Junginger HE, Midha KK, Shah VP, et al. Biowaiver monographs for immediate release solid Oral dosage forms: furosemide. J Pharm Sci. 2010;99:2544\u201356. https:\/\/doi.org\/10.1002\/jps.22030.","journal-title":"J Pharm Sci"},{"key":"1796_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1211\/0022357011775721","volume":"53","author":"T Terao","year":"2001","unstructured":"Terao T, Matsuda K, Shouji H. Improvement in site-specific intestinal absorption of furosemide by Eudragit L100-55. J Pharm Pharmacol. 2001;53:433\u201340. https:\/\/doi.org\/10.1211\/0022357011775721.","journal-title":"J Pharm Pharmacol"},{"key":"1796_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijpharm.2016.03.050","volume":"504","author":"LH Nielsen","year":"2016","unstructured":"Nielsen LH, Melero A, Keller SS, Jacobsen J, Garrigues T, Rades T, et al. Polymeric microcontainers improve oral bioavailability of furosemide. Int J Pharm. 2016;504:98\u2013109. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.050.","journal-title":"Int J Pharm"},{"key":"1796_CR40","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1021\/jm901846t","volume":"53","author":"A Avdeef","year":"2010","unstructured":"Avdeef A, Tam KY. How well can the Caco-2\/Madin\u2212Darby canine kidney models predict effective human Jejunal permeability? J Med Chem. 2010;53:3566\u201384. https:\/\/doi.org\/10.1021\/jm901846t.","journal-title":"J Med Chem"},{"key":"1796_CR41","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1021\/bi702126p","volume":"47","author":"S Gul","year":"2008","unstructured":"Gul S, Hussain S, Thomas MP, Resmini M, Verma CS, Thomas EW, et al. Generation of nucleophilic character in the Cys25\/His159 ion pair of papain involves Trp177 but not Asp158. Biochemistry. 2008;47:2025\u201335. https:\/\/doi.org\/10.1021\/bi702126p.","journal-title":"Biochemistry."},{"key":"1796_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0022-2836(84)90467-4","volume":"179","author":"IG Kamphuis","year":"1984","unstructured":"Kamphuis IG, Kalk KH, Swarte MB, Drenth J. Structure of papain refined at 1.65 A resolution. J Mol Biol. 1984;179:233\u201356.","journal-title":"J Mol Biol"},{"key":"1796_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.biomaterials.2010.09.036","volume":"32","author":"J Iqbal","year":"2011","unstructured":"Iqbal J, Sarti F, Perera G, Bernkop-Schn\u00fcrch A. Development and in vivo evaluation of an oral drug delivery system for paclitaxel. Biomaterials. 2011;32:170\u20135. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.09.036.","journal-title":"Biomaterials."},{"key":"1796_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","volume":"364","author":"EL McConnell","year":"2008","unstructured":"McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 2008;364:213\u201326. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.05.012.","journal-title":"Int J Pharm"},{"key":"1796_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpb.2013.12.012","volume":"87","author":"C M\u00fcller","year":"2014","unstructured":"M\u00fcller C, Perera G, K\u00f6nig V, Bernkop-Schn\u00fcrch A. Development and in vivo evaluation of papain-functionalized nanoparticles. Eur J Pharm Biopharm. 2014;87:125\u201331. https:\/\/doi.org\/10.1016\/j.ejpb.2013.12.012.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","volume":"48","author":"\u00c5 Sj\u00f6berg","year":"2013","unstructured":"Sj\u00f6berg \u00c5, Lutz M, Tannergren C, Wingolf C, Borde A, Ungell AL. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Eur J Pharm Sci. 2013;48:166\u201380. https:\/\/doi.org\/10.1016\/j.ejps.2012.10.007.","journal-title":"Eur J Pharm Sci"},{"key":"1796_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","volume":"106","author":"P Lundquist","year":"2016","unstructured":"Lundquist P, Artursson P. Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues. Adv Drug Deliv Rev. 2016;106:256\u201376. https:\/\/doi.org\/10.1016\/j.addr.2016.07.007.","journal-title":"Adv Drug Deliv Rev"},{"key":"1796_CR48","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/jid.2015.58","volume":"135","author":"C Stremnitzer","year":"2015","unstructured":"Stremnitzer C, Manzano-Szalai K, Willensdorfer A, Starkl P, Pieper M, K\u00f6nig P, et al. Papain degrades tight junction proteins of human keratinocytes in vitro and sensitizes C57BL\/6 mice via the skin independent of its enzymatic activity or TLR4 activation. J Invest Dermatol. 2015;135:1790\u2013800. https:\/\/doi.org\/10.1038\/jid.2015.58.","journal-title":"J Invest Dermatol"},{"key":"1796_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1567201052772834","volume":"2","author":"MJ Cano-Cebri\u00e1n","year":"2005","unstructured":"Cano-Cebri\u00e1n MJ, Zornoza T, Granero L, Polache A. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery. Curr Drug Deliv. 2005;2:9\u201322.","journal-title":"Curr Drug Deliv"},{"key":"1796_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejps.2018.02.028","volume":"117","author":"EC G\u00f3mez","year":"2018","unstructured":"G\u00f3mez EC, Anguiano Igea S, G\u00f3mez Amoza JL, Otero Espinar FJ. Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration. Eur J Pharm Sci. 2018;117:270\u20138. https:\/\/doi.org\/10.1016\/j.ejps.2018.02.028.","journal-title":"Eur J Pharm Sci"},{"key":"1796_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1248\/bpb.35.745","volume":"35","author":"M Wang","year":"2012","unstructured":"Wang M, Sun B, Feng J, Zhang H, Liu B, Li C, et al. Investigation of transport mechanism of exendin-4 across Madin Darby canine kidney cell monolayers. Biol Pharm Bull. 2012;35:745\u201352. https:\/\/doi.org\/10.1248\/bpb.35.745.","journal-title":"Biol Pharm Bull"},{"key":"1796_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","volume":"61","author":"RA Cone","year":"2009","unstructured":"Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61:75\u201385. https:\/\/doi.org\/10.1016\/j.addr.2008.09.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"1796_CR53","first-page":"10","volume":"4","author":"G Lorkowski","year":"2012","unstructured":"Lorkowski G. Gastrointestinal absorption and biological activities of serine and cysteine proteases of animal and plant origin: review on absorption of serine and cysteine proteases. Int J Physiol Pathophysiol Pharmacol. 2012;4:10\u201327.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"1796_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.addr.2017.10.004","volume":"124","author":"C Menzel","year":"2018","unstructured":"Menzel C, Bernkop-Schn\u00fcrch A. Enzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrier. Adv Drug Deliv Rev. 2018;124:164\u201374. https:\/\/doi.org\/10.1016\/j.addr.2017.10.004.","journal-title":"Adv Drug Deliv Rev"},{"key":"1796_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ejps.2005.04.015","volume":"25","author":"RA Des","year":"2005","unstructured":"Des RA, EGE R, Gullberg E, Pr\u00e9at V, Schneider YJ, Artursson P. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci. 2005;25:455\u201365. https:\/\/doi.org\/10.1016\/j.ejps.2005.04.015.","journal-title":"Eur J Pharm Sci"},{"key":"1796_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2015.01.028","volume":"481","author":"D Antoine","year":"2015","unstructured":"Antoine D, Pellequer Y, Tempesta C, Lorscheidt S, Kettel B, Tamaddon L, et al. Biorelevant media resistant co-culture model mimicking permeability of human intestine. Int J Pharm. 2015;481:27\u201336. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.01.028.","journal-title":"Int J Pharm"},{"issue":"Suppl 8","key":"1796_CR57","doi-asserted-by":"publisher","first-page":"P67","DOI":"10.1186\/1753-6561-5-S8-P67","volume":"5","author":"A Bazes","year":"2011","unstructured":"Bazes A, Nollevaux G, Coco R, Joly A, Sergent T, Schneider YJ. Development of a triculture based system for improved benefit\/risk assessment in pharmacology and human food. BMC Proc. 2011;5(Suppl 8):P67. https:\/\/doi.org\/10.1186\/1753-6561-5-S8-P67.","journal-title":"BMC Proc"},{"key":"1796_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ejps.2006.12.006","volume":"30","author":"A des Rieux","year":"2007","unstructured":"des Rieux A, Fievez V, Th\u00e9ate I, Mast J, Pr\u00e9at V, Schneider YJ. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur J Pharm Sci. 2007;30:380\u201391. https:\/\/doi.org\/10.1016\/j.ejps.2006.12.006.","journal-title":"Eur J Pharm Sci"},{"key":"1796_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejpb.2016.12.004","volume":"118","author":"D Lichtenstein","year":"2017","unstructured":"Lichtenstein D, Ebmeyer J, Meyer T, Behr AC, K\u00e4stner C, B\u00f6hmert L, et al. It takes more than a coating to get nanoparticles through the intestinal barrier in vitro. Eur J Pharm Biopharm. 2017;118:21\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2016.12.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"1796_CR60","doi-asserted-by":"publisher","unstructured":"Sakhon OS, Ross B, Gusti V, Pham AJ, Vu K, Lo DD. M cell-derived vesicles suggest a unique pathway for trans-epithelial antigen delivery. Tissue Barriers. 2015;3. https:\/\/doi.org\/10.1080\/21688370.2015.1004975.","DOI":"10.1080\/21688370.2015.1004975"},{"key":"1796_CR61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.277.5328.949","volume":"277","author":"S Kern\u00e9is","year":"1997","unstructured":"Kern\u00e9is S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer\u2019s patch lymphocytes of human enterocytes into M cells that transport bacteria. Science (80-). 1997;277:949\u201352. https:\/\/doi.org\/10.1126\/science.277.5328.949.","journal-title":"Science (80-)"},{"key":"1796_CR62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mi.2013.30","volume":"6","author":"NA Mabbott","year":"2013","unstructured":"Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013;6:666\u201377. https:\/\/doi.org\/10.1038\/mi.2013.30.","journal-title":"Mucosal Immunol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01796-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01796-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01796-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:31:08Z","timestamp":1630711868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01796-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1796"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01796-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"255"}}